Additively enhanced antiproliferative effect of interferon combined with proanthocyanidin on bladder cancer cells

Journal of Cancer

Volumn 3, Issue 1, 2012, Pages 107-112

  Fishman, Andrew I ^a   Johnson, Blake ^a   Alexander, Bobby ^a   Won, John ^a   Choudhury, Muhammad ^a   Konno, Sensuke ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

Bladder cancer; Combination therapy; Interferon; Proanthocyanidin

Indexed keywords

CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE 4; CYCLIN E; PROANTHOCYANIDIN; PROTEIN P27; RECOMBINANT ALPHA2B INTERFERON;

ANTIPROLIFERATIVE ACTIVITY; ARTICLE; BLADDER CANCER; CANCER CELL; CANCER GROWTH; CANCER INHIBITION; CELL CYCLE; DRUG EFFICACY; G1 PHASE CELL CYCLE CHECKPOINT; HUMAN; HUMAN CELL; IN VITRO STUDY; WESTERN BLOTTING;

EID: 84863638760     PISSN: None     EISSN: 18379664     Source Type: Journal    
DOI: 10.7150/jca.4107     Document Type: Article

References (25)

1. Pow-Sang JM, Seigne JD. Contemporary management of su-perficial bladder cancer. Cancer Control. 2000; 7: 335-9.
2. Witjes JA, Mulders PF, Debruyne FM. Intravesical therapy in superficial bladder cancer. Urology. 1994; 43: 2-5.
3. Alexandroff AB, Jackson AM, O'Donnell MA, James K. BCG immunotherapy of bladder cancer: 20 years on. Lancet. 1999; 353: 1689-94.
4. Lamm DL, Blumenstein BA, Crawford ED, et al. A randomized trial of intravesical doxorubicin and immunotherapy with ba-cillus Calmette-Guerin for transitional-cell carcinoma of the bladder. N Engl J Med. 1991; 325: 1205-9.
5. Herr HW, Schwalb DM, Zhang ZF, et al. Intravesical bacillus Calmette-Guerin therapy prevents tumor progression and death from superficial bladder cancer: ten-year follow-up of a prospective randomized trial. J Clin Oncol. 1995; 13: 1404-8.
6. Amling CL. Diagnosis and management of superficial bladder cancer. Curr Probl Cancer. 2001; 25: 219-78.
7. Harris DT, Matyas GR, Gomella LG, et al. Immunologic approaches to the treatment of prostate cancer. Semin Oncol. 2000; 26: 439-47.
8. Glashan RW. A randomized controlled study of intravesical alpha-2b-interferon in carcinoma in situ of the bladder. J Urol. 1990; 144: 658-61.
9. Bukowski RM. Cytokine therapy for metastatic renal cell carcinoma. Semin Urol Oncol. 2001; 19: 148-54.
10. Belldegrun AS, Franklin JR, O'Donnell MA, et al. Superficial bladder cancer: the role of interferon-alpha. J Urol. 1998; 159: 1793-1801.
11. Stricker P, Pryor K, Nicholson T, et al. Bacillus Calmette-Guerin plus intravesical interferon alpha-2b in patients with superficial bladder cancer. Urology. 1996; 48: 957-61.
12. Gan YH, Zhang Y, Khoo HE, Esuvaranathan K. Antitumor immunity of Bacillus Calmette-Guerin and interferon alpha in murine bladder cancer. Eur J Cancer. 1999; 35: 1123-9.
13. Bagchi D, Garg A, Krohn RL, Bagchi M, Tran MX, Stohs SJ. Oxygen free radical scavenging abilities of vitamins C and E, and a grape seed proanthocyanidin extract in vitro. Res Commun Mol Pathol Pharmacol. 1997; 95: 179-89.
14. Bagchi D, Kuszynski CA, Balmoori J, Bagchi M, Stohs SJ. Hy-drogen peroxide-induced modulation of intracellular oxidized states in cultured macrophage J774A.1 and neuroactive PC-12 cells, and protection by a novel grape seed proanthocyanidin extract. Phytother Res. 1998; 12: 568-71.
15. Joshi SS, Kuszynski CA, Bagchi M, Bagchi D. Chemopreventive effects of grape seed proanthocyanidin extract on Chang liver cells. Toxicology. 2000; 155: 83-90.
16. Ye X, Krohn RL, Liu W, et al. The cytotoxic effects of a novel IH636 grape seed proanthocyanidin extract on cultured human cancer cells. Mol Cell Biochem. 1999; 196: 99-108.
17. Mordente JA, Konno S, Chen Y, Wu JM, Tazaki H, Mallouh C. The effects of brefeldin A (BFA) on cell cycle progression in-volving the modulation of the retinoblastoma protein (pRB) in PC-3 prostate cancer cells. J Urol. 1998; 159: 275-9.
18. Sherr CJ. The Pezcoller lecture: cancer cell cycles revised. Can-cer Res. 2000; 60: 3689-95.
19. Luo Y, Chen X, Han R, O'Donnell MA. Recombinant bacille Calmette-Guerin (BCG) expressing human interferon-alpha 2B demonstrates enhanced immunogenicity. Clin Exp Immunol. 2001; 123: 264-70.
20. Bandyopadhyay SK, Rackley RR, Matin SF, Sadhukhan PC. Interferon-α response and signal transduction pathway in transitional carcinoma cell lines. Adv Exp Med Biol. 2003; 539 (Pt A): 15-32.
21. Singh RP, Tyagi AK, Dhanalakshmi S, Agarwal R, Agarwal C. Grape seed extract inhibits advanced human prostate tumor growth and angiogenesis and upregulates insulin-like growth factor binding protein-3. Int J Cancer. 2004; 108: 733-40.
22. Mantena SK, Baliga MA, Katiyar SK. Grape seed proanthocya-nidins induce apoptosis and inhibit metastasis of highly meta-static breast carcinoma cells. Carcinogenesis. 2006; 27: 1682-91.
23. Zhang XY, Bai DC, Wu YJ, Li WG, Liu NF. Proanthocyanidin from grape seeds enhances anti-tumor effect of doxorubicin both in vitro and in vivo. Pharmazie. 2005; 60: 533-8.
24. Bagchi D, Bagchi M, Stohs SJ, et al. Free radicals and grape seed proanthocyanidin extract: importance in human health and disease prevention. Toxicology. 2000; 148: 187-97.
25. Banerjee B, Bagchi D. Beneficial effects of a novel IH636 grape seed proanthocyanidin extract in the treatment of chronic pan-creatitis. Digestion. 2001; 63: 203-6.